Belkin Unveils the Auto-Tracking Stand Pro Featuring DockKit, Taking Content Creation to the Next Level
Belkin, a leading consumer electronics brand for 40 years, today introduced the first-ever accessory to work with DockKit – the Auto-Tracking Stand Pro. The all-new Stand Pro provides automatic, silent, motorized, seamless camerawork using iPhone’s built in camera, and DockKit’s automated subject tracking technology to follow subjects on camera as they move around their space with 360 degrees of pan and 90 degrees of tilt. It is the perfect accessory for immersive video calls or recording interactive content that involves a high degree of movement.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240107377265/en/
Belkin unveils the Auto-Tracking Stand Pro featuring DockKit, taking content creation to the next level. (Photo: Business Wire)
“The Stand Pro is unlike any other Belkin product we’ve created. Combining premium Belkin quality, impressively responsive robotics, and advanced subject tracking technology with DockKit, we’re excited to provide content creators with a thoughtfully designed product that will effortlessly enhance the creation process,” said Melody Tecson, Belkin’s vice president of product management. “We are proud to deliver the world’s first DockKit-enabled accessory, and we look forward to bringing more content creation products to market.”
Designed for iOS for use with front and rear cameras, DockKit allows users to easily create, present, and record without having to download third party apps in just four easy steps:
- Snap iPhone 12 or later with MagSafe onto Stand Pro using MagSafe
- Pair via NFC
- Open camera on FaceTime, Instagram, TikTok, Canva, WhatsApp, Microsoft Teams or other social media apps or messaging platforms
- Start creating
With the Stand Pro, users can easily extend the field of view to 360 degrees of pan and 90 degrees of tilt by supporting a pitch and yaw motion model and an automatic system tracker. This lets creators focus on the content while DockKit automatically keeps the subject in frame at all angles while capturing natural movements without the need for manual adjustment.
Key features, pricing and availability:
- Made with MagSafe – charge and chat at the same time with fast wireless charging up to 15W when the Stand Pro is plugged in.
- 360º Movement Tracking – movement tracking with DockKit always keeps people in frame no matter how many times they circle the room.
- 90º Motorized Auto Tilt – capture at any angle using front or rear cameras with automatic video angle adjusting for going high or low.
- Single button activation – turn movement tracking on or off with one button; an LED indicator will indicate if tracking is active.
- Rechargeable battery – no wall outlet, no problem; the dock provides 5 hours of battery life for capturing content on-the-go.
- 5ft USB-C cable and 30W power supply included.
The Auto-Tracking Stand Pro is made more responsibly with a minimum of 75% PCR materials and sold in plastic-free packaging in line with the company’s commitment to find more responsible ways to build products.
The Auto-Tracking Stand Pro is $179.99 USD, and is coming soon to Belkin.com and select retailers worldwide. Stay up to date on product availability by selecting “Notify Me” on the website.
Media kit is available for download HERE.
About Belkin
Belkin is a California-based accessories leader delivering award-winning power, protection, productivity, connectivity, and audio products over the last 40 years. Designed and engineered in Southern California and sold in more than 100 countries around the world, Belkin has maintained its steadfast focus on research and development, community, education, sustainability and most importantly, the people it serves. From the humble beginnings of a garage in 1980s Southern California to a diverse, global technology company today, we remain forever inspired by the planet we live on, and the connection between people and technology.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240107377265/en/
Contact information
Jen Wei
VP of Global Communications and Corporate Development
Comms@belkin.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Medicines Announces Positive Topline Results for Sonrotoclax in Relapsed or Refractory Mantle Cell Lymphoma (MCL)29.8.2025 13:00:00 EEST | Press release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced positive topline results from a Phase 1/2 study (BGB-11417-201) of sonrotoclax, a next-generation and potentially best-in-class investigational BCL2 inhibitor, in adult patients with relapsed/refractory (R/R) mantle cell lymphoma (MCL), following treatment with a Bruton’s tyrosine kinase inhibitor (BTKi) and anti-CD20 therapy. BeOne plans to present the full data at an upcoming medical meeting. “For people with relapsed or refractory mantle cell lymphoma, the disease is aggressive, the treatment landscape fragmented, and the outcomes unacceptably poor. These topline results for sonrotoclax underscore its potential to deliver meaningful and durable responses and offer the first BCL2 inhibitor for patients with R/R MCL, if approved,” said Lai Wang, PhD, Global Head of R&D, BeOne Medicines. “These data add to the remarkable progress we’ve seen over the past five years in treating B-cel
Oulu2026 – European Capital of Culture: Oulu to Unveil Full European Capital of Culture 2026 Programme – Live Stream on 4 September 202529.8.2025 11:46:00 EEST | Press release
Hundreds of partners are creating a year in which Northern Finland becomes a new hub of culture. The programme will offer something for everyone: large-scale exhibitions, festivals across all genres, world premieres, performing arts, village celebrations, permanent artworks, sports, and community events across a vast region of 40 municipalities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250829591577/en/ Oulu, with its 39 partner municipalities in Northern Finland, will step into the spotlight as European Capital of Culture 2026. The full programme will be officially launched on Thursday 4 September 2025 in Oulu, streamed live across Europe. The Oulu2026 programme is built around the theme of Cultural Climate Change, meaning a lasting enrichment of cultural life – connecting people through world-class experiences, creativity, and new ways of thinking. “2026 will be a transformative year – for our city, for Northern Finla
Nippon Sanso Holdings Group Unifies Global Brand Logo Launching the "NIPPON SANSO" Brand Worldwide29.8.2025 09:00:00 EEST | Press release
Nippon Sanso Holdings Corporation (President CEO: Toshihiko Hamada) will unify the brand logo for its industrial gas business globally and implement the change in stages. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250828253560/en/ Until now, our group has operated industrial gas businesses worldwide using the same symbol mark, while adapting to each region. To further enhance recognition and understanding of our group as a unified entity among a broad range of stakeholders, and to maximize corporate value and achieve sustainable growth, we have decided to unify the brand for our industrial gas businesses as "NIPPON SANSO" and standardize the brand logo globally. Moving forward, we will continue striving to be a trusted company for all stakeholders as a globally recognized brand. *Please note that Thermos Group, which operates the consumer household goods business within our group, will not change its brand logo. *The log
TOM FORD Unveils Black Orchid Reserve Campaign Starring Tilda Swinton29.8.2025 07:35:00 EEST | Press release
The quest for exceptional rarity. Introducing Tilda Swinton for the new TOM FORD Black Orchid Reserve campaign. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250828507187/en/ “It is a profound honour for me to play a part in the history of TOM FORD’s legendary Black Orchid. Transformation, the blurring of boundaries and the celebration of magical properties have always drawn me close; Black Orchid Reserve is precisely such an enchantment.” — Tilda Swinton A celebrated actor and artist, Swinton is a singular presence known for her fearless artistry and transformative performances. An Academy Award, BAFTA and Golden Lion for Lifetime Achievement winner, Swinton defies conventions with elegance, intellect and a visionary approach to cinema. Her work transcends definition, shaping the culture through work in film, art and performance. TOM FORD creative director Haider Ackermann designed the campaign as a cinematic portrait of r
Novotech Supports Groundbreaking Approval of Anlotinib Combination Therapy for Advanced Soft Tissue Sarcoma28.8.2025 23:15:00 EEST | Press release
Novotech, a globally recognized full-service clinical research organization (CRO), is proud to have partnered with Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CTTQ Pharma) in achieving a significant regulatory milestone: the approval of Anlotinib Hydrochloride Capsules for a new indication as a first-line treatment for unresectable locally advanced or metastatic soft tissue sarcoma (STS) in combination with chemotherapy. This approval marks the ninth indication for Anlotinib in China and represents the world’s first official approval of an Anlotinib-chemotherapy combination for first-line treatment of advanced or metastatic STS. Previously recommended as a second-line monotherapy by the Chinese Society of Clinical Oncology (CSCO) guidelines, Anlotinib was the only Grade I targeted therapy for STS. This new indication represents a significant advancement for patients who have not previously received systemic treatment, expanding access to more effective and targeted first-line the
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom